Evidence map›Paper›PMID 41484201›Full record

ArticleScientific reports2026

Transcriptomic and genomic analysis of successful Ethiopian Mycobacterium tuberculosis sub-lineage 4.2.2.2 reveals differential expression of DosR-regulated genes.

Tesfaye Gebreyohannis Hailemariam, Abaysew Ayele, Tesfaye Gelanew, Michael Brennan, Kayleigh Floyd, Zemedkun Abebe Debella, Workineh Shibeshi, Kidist Bobosha, Yonas K Hirutu, Simon J Waddell and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tesfaye Gebreyohannis HailemariamDepartment of Pharmacology and Clinical Pharmacy School of Pharmacy, College of Health Science, Addis Ababa University , Addis Ababa, Ethiopia.
Abaysew AyeleArmauer Hansen Research Institute (AHRI) , Addis Ababa, Ethiopia.
Tesfaye GelanewArmauer Hansen Research Institute (AHRI) , Addis Ababa, Ethiopia.
Michael BrennanDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex , Brighton, BN1 9PX, UK.
Kayleigh FloydDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex , Brighton, BN1 9PX, UK.
Zemedkun Abebe DebellaAddis Ababa Institute of Technology , Addis Ababa, Ethiopia.
Workineh ShibeshiDepartment of Pharmacology and Clinical Pharmacy School of Pharmacy, College of Health Science, Addis Ababa University , Addis Ababa, Ethiopia.
Kidist BoboshaArmauer Hansen Research Institute (AHRI) , Addis Ababa, Ethiopia.
Yonas K HirutuArmauer Hansen Research Institute (AHRI) , Addis Ababa, Ethiopia.
Simon J WaddellDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex , Brighton, BN1 9PX, UK. S.Waddell@bsms.ac.uk.
Ephrem EngidaworkDepartment of Pharmacology and Clinical Pharmacy School of Pharmacy, College of Health Science, Addis Ababa University , Addis Ababa, Ethiopia. ephrem.engidawork@aau.edu.et.

Funding

Addis Ababa University PhD Research projectArmauer Hansen Research Institute TBGene projectWellcome Trust
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) sub-lineage 4.2.2.2 is the most frequently isolated strain of Mtb from Ethiopian treatment-refractory tuberculosis patients. This study investigated the underlying molecular background to Mtb sub-lineage 4.2.2.2 through transcriptomic and genomic analyses. Comparative whole genome sequencing and transcriptomics (RNAseq) was performed with other circulating clinical Ethiopian lineages and sub-lineages: lineage 7, lineage 3, lineage 4 sub-lineage 4.1.2.1, and sub-lineage 4.6.3. We identified seven genes differentially expressed in sub-lineage 4.2.2.2 compared to other Mtb lineages. Of these, six (Rv0331, Rv0720, Rv1993c, Rv2030c, Rv2034 and Rv3129) were upregulated, while Rv0997a was downregulated. These differentially expressed genes are associated with lipid metabolism, stress responses, protein synthesis and metal transport, suggesting that sub-lineage 4.2.2.2 may be better able to adapt to the complex host-pathogen interactions of infection and transmission. Interestingly, this observation is mirrored by mild induction of DosR-regulated genes in sub-lineage 4.2.2.2 compared to other lineages in vitro, suggesting that enhanced expression of the DosR regulon may influence this sub-lineage’s ability to cause disease in Ethiopia. Taken together, our findings reveal genes that might impact the pathogenicity of Mtb clinical isolates in Ethiopia and identifies single nucleotide polymorphisms that could influence their expression.

Indexed as

Bacterial ProteinsGene Expression Regulation, BacterialMycobacterium tuberculosisProtein KinasesTranscriptomeTuberculosisDNA-Binding ProteinsEthiopiaGene Expression ProfilingGenomicsHumansWhole Genome SequencingBacterial ProteinsDNA-Binding ProteinsDosR protein, Mycobacterium tuberculosisProtein KinasesDosR regulonEthiopiaMycobacterium tuberculosis sub-lineage 4.2.2.2TranscriptomicsWhole genome sequencing

Identifiers

PMID41484201
PMCPMC12859060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.